Irbesartan
59 NDCs across 11 manufacturers|57 Generic,2 Brand
Irbesartan is used to treat diabetic nephropathies, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 30, 1997, and the first generic was approved Mar 30, 2012. FDA's Orange Book lists 47 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $57 million on Irbesartan across 2.6 million claims for 631,000 beneficiaries.
Irbesartan is available as 59 NDCs from 11 manufacturers (57 generic, 2 brand), with NADAC prices from $0.08 to $8.79 per EA — the most expensive product costs about 107× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
59
57G / 2B
Manufacturers
11
competing in market
Price Spread
$0.08 – $8.79
per EA
7d Activity
avg +0.0% WoW · of 59 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Solco Healthcare US LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin 2 Receptor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing IRBESARTAN(1 pricing outlier)
Frequently Asked Questions
What is Irbesartan used to treat?
Irbesartan is used to treat diabetic nephropathies, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Irbesartan become available as a generic?
FDA approved the first generic Irbesartan (ANDA) on Mar 30, 2012. The Orange Book currently lists 47 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Irbesartan?
In 2024, Medicare Part D spent $57 million on Irbesartan across 2.6 million claims for 631,000 beneficiaries.
How many Irbesartan products are on the market?
The Irbesartan drug market contains 59 NDCs from 11 manufacturers — 57 generic and 2 brand products.
What is the price range for Irbesartan?
NADAC reference prices for Irbesartan range from $0.0823 to $8.7919 per EA — the most expensive product costs about 107× the cheapest.
Is generic Irbesartan cheaper than brand?
The average generic NADAC for Irbesartan is $0.1445 per EA, versus $8.0684 for brand-labeled products — brand versions average about 56× the generic price.
Which manufacturers make Irbesartan?
11 manufacturers list Irbesartan in NADAC. Ranked by number of NDCs, the largest are Solco Healthcare US LLC (9), Aurobindo Pharma Limited (8), Alembic Pharmaceuticals Inc. (8), Camber Pharmaceuticals Inc. (7), Jubilant Cadista Pharmaceuticals Inc. (6).
How has the price of Irbesartan changed recently?
Over the past 7 days, 13 Irbesartan NDCs rose and 27 fell, with a market-wide average change of +0.0%.